MiNK Therapeutics (INKT) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

MiNK Therapeutics (INKT) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

MiNK Therapeutics

· INKT

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

61.879 M

-3.38%

General

Market Cap: $64.04M
Enterprise Value: $53.29M
Shares Outstanding: 4,980,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -118.15%
ROE: 83.45%
ROIC: -604.20%
Current Ratio: 1.23
Debt-to-Equity: —
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: —
EV/EBITDA: -4.45

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $12.21M
Operating Income: -$12.36M
Net Profit: -$11.36M

Balance Sheet

Cash and Equivalents: $8.81M
Working Capital: $1.73M
Total Assets: $9.62M
Net Debt: -$8.81M
Total Liabilities: $23.64M
Total Equity: -$14.03M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$6.83M
Cash Flow from Investing: —
Cash Flow from Financing: $13.99M
Free Cash Flow: -$6.83M
Capital Expenditures: $5